Mc Lean Asset Management Corp Edwards Lifesciences Corp Transaction History

Mc Lean Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 07, 2022	SELL	$86.5 - $128.27 $174,384 - $258,592	-2,016 Closed	0 $0
Q1 2022 Apr 08, 2022	BUY	$101.96 - $128.34 $4,996 - $6,288	49 Added 2.49%	2,016 $237,000
Q4 2021 Jan 14, 2022	SELL	$106.37 - $130.68 $2,552 - $3,136	-24 Reduced 1.21%	1,967 $240,000
Q3 2021 Oct 27, 2021	BUY	$102.91 - $122.75 $2,469 - $2,946	24 Added 1.22%	1,991 $233,000
Q2 2021 Jul 19, 2021	BUY	$83.84 - $104.76 $164,913 - $206,062	1,967 New	1,967 $210,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Mc Lean Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Mc Lean Asset Management Corp with notifications on news.